4.7 Article

Structural characterization and amelioration of sulfated polysaccharides from Ganoderma applanatum residue against CCl4-induced hepatotoxicity

期刊

INTERNATIONAL IMMUNOPHARMACOLOGY
卷 96, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.intimp.2021.107554

关键词

Anti-fibrosis; Antioxidant; Ganoderma applanatum residue; Hepatotoxicity; Sulfated-polysaccharides

资金

  1. Mushroom Technology System of Shandong Province [SDAIT-07-05]
  2. Shandong Key Research and Development Program [2019GSF107208]

向作者/读者索取更多资源

This study demonstrates the hepatoprotective effects of sulfated Ganoderma applanatum residue polysaccharides (SGRP) on chronic liver injury induced by CCl4, showing reduction in histopathological damages, improvement in liver function, decrease in inflammation, and antioxidant properties. Structural studies reveal SGRP as a heteropolysaccharide with high sulfur content. Our findings suggest SGRP as a potential candidate for anti-fibrosis treatment in pharmaceutical industries or as a food supplement.
Natural polysaccharides and their derivatives have attracted academic attention due to their extensive physiological activities. However, the hepatoprotective effects against carbon tetrachloride (CCl4) toxicity have not been well elucidated. The objectives of this study were to characterize the structural properties of sulfated Ganoderma applanatum residue polysaccharides (SGRP) and to evaluate their inhibitory effects on liver fibrosis caused by oxidative stress and inflammation. Our in vivo study showed that SGRP was hepatoprotective in CCl4induced chronic liver injury mice. It reduced the histopathological damages, down-regulated CYP2E1 (cytochrome P450 2E1) expression, reduced serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels, improved the anti-oxidative and anti-inflammatory properties, inhibited TLR4/NF-kappa B signaling pathway, and reduced the release of inflammatory cytokines. The structural studies indicated that SGRP is a heteropolysaccharide with 7.8% sulfur content and alpha-linked residue. Our study projects SGRP as a potential candidate in anti-fibrosis treatment by using it as a food supplement or in medicines produced by pharmaceutical industries.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据